Potential for combination therapy with the new antiserotonergic agents
- 31 December 1993
- journal article
- Published by Elsevier in European Journal Of Cancer
- Vol. 29, S39-S41
- https://doi.org/10.1016/s0959-8049(05)80260-6
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Does dexamethasone enhance control of acute cisplatin induced emesis by ondansetron?BMJ, 1991
- Comparison of ondansetron and ondansetron plus dexamethasone as antiemetic prophylaxis during cisplatin-containing chemotherapyThe Lancet, 1991
- ONDANSETRON WITH AND WITHOUT DEXAMETHASONE TO TREAT CHEMOTHERAPY-INDUCED EMESISThe Lancet, 1989
- Potential use of drugs modulating 5HT activity in the treatment of anxietyGeneral Pharmacology: The Vascular System, 1988
- The serotonin type 3 receptor antagonist BRL 43694 and nausea and vomiting induced by cisplatin.BMJ, 1988
- Comparison of Metoclopramide and Metoclopramide Plus Dexamethasone for Complete Protection from Cisplatinum-Induced EmesisCancer Investigation, 1986
- Dexamethasone and high dose metoclopramide: efficacy in controlling cisplatin induced nausea and vomiting.BMJ, 1984
- ANTIEMETICS: NEUROTRANSMITTER RECEPTOR BINDING PREDICTS THERAPEUTIC ACTIONSThe Lancet, 1982
- Antiemetic Efficacy of High-Dose Metoclopramide: Randomized Trials with Placebo and Prochlorperazine in Patients with Chemotherapy-Induced Nausea and VomitingNew England Journal of Medicine, 1981
- Blockade of neuronal tryptamine receptors by metoclopramideEuropean Journal of Pharmacology, 1978